FR2773157B1 - PEPTIDE EPITOPES RECOGNIZED BY ANTIFILAGGRIN AUTOANTIBODIES PRESENT IN THE SERUM OF PATIENTS WITH RHUMATOID POLYARTHRITIS - Google Patents

PEPTIDE EPITOPES RECOGNIZED BY ANTIFILAGGRIN AUTOANTIBODIES PRESENT IN THE SERUM OF PATIENTS WITH RHUMATOID POLYARTHRITIS

Info

Publication number
FR2773157B1
FR2773157B1 FR9716673A FR9716673A FR2773157B1 FR 2773157 B1 FR2773157 B1 FR 2773157B1 FR 9716673 A FR9716673 A FR 9716673A FR 9716673 A FR9716673 A FR 9716673A FR 2773157 B1 FR2773157 B1 FR 2773157B1
Authority
FR
France
Prior art keywords
serum
patients
peptide epitopes
epitopes recognized
autoantibodies present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9716673A
Other languages
French (fr)
Other versions
FR2773157A1 (en
Inventor
Guy Bruno Rene Serre
Neuhauser Elisabeth Girbal
Christian Vincent
Michel Simon
Mireille Sebbag
Pascal Dalbon
Reynaud Colette Jolivet
Michel Arnaud
Michel Jolivet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Priority to FR9716673A priority Critical patent/FR2773157B1/en
Priority to PCT/FR1998/002899 priority patent/WO1999035167A1/en
Priority to CA002316269A priority patent/CA2316269A1/en
Priority to AU19717/99A priority patent/AU1971799A/en
Priority to EP98964536A priority patent/EP1042366A1/en
Publication of FR2773157A1 publication Critical patent/FR2773157A1/en
Application granted granted Critical
Publication of FR2773157B1 publication Critical patent/FR2773157B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Rehabilitation Therapy (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
FR9716673A 1997-12-30 1997-12-30 PEPTIDE EPITOPES RECOGNIZED BY ANTIFILAGGRIN AUTOANTIBODIES PRESENT IN THE SERUM OF PATIENTS WITH RHUMATOID POLYARTHRITIS Expired - Fee Related FR2773157B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9716673A FR2773157B1 (en) 1997-12-30 1997-12-30 PEPTIDE EPITOPES RECOGNIZED BY ANTIFILAGGRIN AUTOANTIBODIES PRESENT IN THE SERUM OF PATIENTS WITH RHUMATOID POLYARTHRITIS
PCT/FR1998/002899 WO1999035167A1 (en) 1997-12-30 1998-12-29 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients
CA002316269A CA2316269A1 (en) 1997-12-30 1998-12-29 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients
AU19717/99A AU1971799A (en) 1997-12-30 1998-12-29 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients
EP98964536A EP1042366A1 (en) 1997-12-30 1998-12-29 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9716673A FR2773157B1 (en) 1997-12-30 1997-12-30 PEPTIDE EPITOPES RECOGNIZED BY ANTIFILAGGRIN AUTOANTIBODIES PRESENT IN THE SERUM OF PATIENTS WITH RHUMATOID POLYARTHRITIS

Publications (2)

Publication Number Publication Date
FR2773157A1 FR2773157A1 (en) 1999-07-02
FR2773157B1 true FR2773157B1 (en) 2001-10-05

Family

ID=9515272

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9716673A Expired - Fee Related FR2773157B1 (en) 1997-12-30 1997-12-30 PEPTIDE EPITOPES RECOGNIZED BY ANTIFILAGGRIN AUTOANTIBODIES PRESENT IN THE SERUM OF PATIENTS WITH RHUMATOID POLYARTHRITIS

Country Status (5)

Country Link
EP (1) EP1042366A1 (en)
AU (1) AU1971799A (en)
CA (1) CA2316269A1 (en)
FR (1) FR2773157B1 (en)
WO (1) WO1999035167A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773078B1 (en) * 1997-12-30 2000-05-26 Univ Toulouse USE OF CITRULLIN PEPTIDES DERIVED FROM FILAGGRIN FOR THE TREATMENT OF RHUMATOID POLYARTHRITIS
EP1240180A2 (en) * 1999-12-21 2002-09-18 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
FR2826124B1 (en) * 2001-06-13 2004-01-02 Bio Merieux METHOD FOR THE DETECTION OF RHUMATOID POLYARTHRITIS SPECIFIC SELF-ANTIBODIES
NL1019540C2 (en) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Method for detecting autoantibodies from patients suffering from rheumatoid arthritis, peptide and assay kit.
JP4495168B2 (en) 2003-12-23 2010-06-30 エフ．ホフマン−ラ ロシュ アーゲー Method for evaluating rheumatoid arthritis by measuring anti-CCP and interleukin-6
WO2005085858A1 (en) 2004-02-27 2005-09-15 Roche Diagnostics Gmbh Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a
CA2663730A1 (en) 2006-09-29 2008-04-03 F. Hoffmann-La Roche Ag Assessing the risk of disease progression for a patient with rheumatoid arthritis
EP2336769A1 (en) 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Trigger assay for differentiating between rheumatic and non-rheumatic disorders
WO2016128348A1 (en) 2015-02-13 2016-08-18 F. Hoffmann-La Roche Ag Method of assessing rheumatoid arthritis by measuring anti-ccp and anti-pik3cd
EP3056903A1 (en) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-Casp8
EP3056904A1 (en) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-MCM3

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752842B1 (en) * 1996-08-30 1998-11-06 Biomerieux Sa ANTIGENS DERIVED FROM FILAGGRINS AND THEIR USE FOR THE DIAGNOSIS OF RHUMATOID POLYARTHRITIS

Also Published As

Publication number Publication date
CA2316269A1 (en) 1999-07-15
FR2773157A1 (en) 1999-07-02
AU1971799A (en) 1999-07-26
WO1999035167A1 (en) 1999-07-15
EP1042366A1 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
NO991449D0 (en) Antibody to human parathormone-related peptides
DE69625597D1 (en) I / O PROCESSOR ARCHITECTURE WITH INTEGRATED PCI-PCI BRIDGE
IS5375A (en) KAY-Innovative Immune Protein
NO980915L (en) Recombinant anti-CD4 antibody suitable for human therapy
NO985464D0 (en) Concentrated antibody preparation
FI965030A0 (en) N-terminally extended proteins expressed in yeast
DE69319662T2 (en) Monoclonal antibodies to GP130 protein
DE69625233D1 (en) FITTING OF THE FLIPCHIP TYPE
NO960956D0 (en) Recombinant IL4 antibodies useful in the treatment of IL4-related disorders
FR2773157B1 (en) PEPTIDE EPITOPES RECOGNIZED BY ANTIFILAGGRIN AUTOANTIBODIES PRESENT IN THE SERUM OF PATIENTS WITH RHUMATOID POLYARTHRITIS
DE69531958D1 (en) (1-3) -BETA-D-GLUUCON-BINDING PROTEIN, ANTIBODY DETECTING THIS PROTEIN AND USE OF THE PROTEIN AND ANTIBODY
NO970047D0 (en) Streptogramins and their preparation by mutasynthesis
FI952069A0 (en) Low allergenic proteins
DE58900884D1 (en) OPENING AID FOR AMPOULES.
FI972030A0 (en) Purified papillomavirus proteins
FR2631239B1 (en) HUMAN MONOCLONAL ANTIBODIES AND HYBRIDOMA PRODUCING THE SAME
ATA74890A (en) SEPARATOR FOR LIGHTING LIQUIDS
ITTO960496A0 (en) MODIFICATION OF POLYPEPTIDE DRUGS TO INCREASE THE FLOW FOR ELECTROTRANSPORT.
FI964606A (en) Factor interacting with nuclear proteins
DE69431829T2 (en) Fastening element for securing the position of electrode connection points
DK0655503T3 (en) Process for the preparation of human serum albumin
DE3687542T2 (en) MONOCLONAL ANTIBODY AGAINST HUMAN PROTEIN C.
DE69420044D1 (en) BLOOD REGULATING PEPTIDES
NO20006091D0 (en) Human protein C polypeptide
DE69434900D1 (en) HUMAN CHEMOKIN POLYPEPTIDE

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060831